Company intelligence
Myriad Genetics
Leading molecular diagnostic testing & precision medicine company dedicated to advancing health and well-being for all.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs.
Verified activity
Signals from Myriad Genetics
5 published signals
Products & Services
Myriad Genetics expanded access to faster hereditary cancer testing for both endometrial and ovarian cancer patients.
Reported by Myriad Genetics
People
Myriad Genetics employee Betsy Bailey joined Guardant Health Health as an Account Executive- Oncology.
Reported by Betsy Bailey
Research & Knowledge
Myriad Genetics published a study of more than 8,000 women showing that an elevated RiskScore result is associated with increased adoption of risk-appropriate breast cancer screening and surveillance, including breast MRI, even when Tyrer-Cuzick is not elevated.
Reported by Myriad Genetics
Products & Services
Myriad Genetics launched the Prolaris + AI Test, a personalized prostate cancer test that provides insights about an individual's prostate cancer to help patients and providers navigate active surveillance, treatment, and what comes next.
Reported by Myriad Genetics
Research & Knowledge
Myriad Genetics published clinical evidence showing that the RiskScore analysis is a component of the MyRisk Hereditary Cancer Test that accurately predicts future breast cancer risk in over 650,000 women across multiple clinical studies with more than 15 years of follow up.
Reported by Myriad Genetics